INTEGRA LIFESCIENCES HOLDINGS CORP
Company Stats
- Market Cap
- $1.3B
- as of Sep 30, 2026
- Shares Outstanding
- 77.8M
- Free Float
- 98.0%
Income Statement
- Revenue
- $1.6B
- Operating Income
- -$493.4M
- Net Income
- -$516.5M
- EBITDA
- -$448.6M
- Non-cash Impairment
- $511.4M
- Revenue Growth, 3Y
- 1.6%
- FCF Margin, 3Y Avg
- 1.5%
- FCF Margin, Worst Year
- -1.9%
Cash Flow
- Free Cash Flow
- -$31.1M
- FCF Yield
- -2.5%
- Owner FCF Yield
- -3.9%
Balance Sheet
- Cash & Equivalents
- $235.0M
Returns & Capital
- Share Repurchases
- $221,000
- Buyback Yield, 3Y Avg
- 8.6%
- SBC, 3Y Avg
- $21.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $1.6B | -$31.1M | -1.9% |
| FY2024 | $1.6B | $25.0M | 1.6% |
| FY2023 | $1.5B | $73.1M | 4.7% |
| FY2022 | $1.6B | $222.1M | 14.3% |
| FY2021 | $1.5B | $264.4M | 17.1% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 8, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Micro-cap earnings: IDT grows as Integra cuts its outlook
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back